BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31732299)

  • 1. The clinical significance of methylation of MAGE-A1 and-A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinoma.
    Liu S; Zhao Y; Xu Y; Sang M; Zhao R; Gu L; Shan B
    Am J Otolaryngol; 2020; 41(1):102318. PubMed ID: 31732299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
    Han L; Jiang B; Wu H; Zhang S; Lu X
    Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethylation of MAGE promoters during gastric cancer progression.
    Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T
    Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
    Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
    World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MAGE-A1, -A9, -A11 in laryngeal squamous cell carcinoma and their prognostic significance: a retrospective clinical study.
    Liu S; Sang M; Xu Y; Gu L; Liu F; Shan B
    Acta Otolaryngol; 2016; 136(5):506-13. PubMed ID: 26766421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methylation status of uPA promoter in laryngeal squamous cell carcinoma].
    Wang D; Wang T; Ren Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(9):409-11. PubMed ID: 16836076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
    Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
    Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
    Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
    Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
    Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
    Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.
    Loriot A; De Plaen E; Boon T; De Smet C
    J Biol Chem; 2006 Apr; 281(15):10118-26. PubMed ID: 16497664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
    Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
    BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
    Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
    Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical pathological implications of carbonic anhydrase 9 and P glycoprotein in laryngeal squamous cell carcinoma].
    Chen X; Wang F; Xie F; Dong P; Ying X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(1):42-4. PubMed ID: 27197454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CBY and methylation of CBY at promoter region in human laryngeal squamous cell carcinoma.
    Ren G; Zhao DA; Xu J; Li BA
    Tumori; 2015; 101(2):215-22. PubMed ID: 25838250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
    Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
    J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.